Loading…
Disclosed for 40 months, Sep 2021 to Aug 2026.
HSBC Midcap Fund is an active equity fund in the Mid Cap category from HSBC Mutual Fund. In September 2021 it disclosed 14 stocks worth ₹1,317 Cr. Its largest positions were Atul Limited (0.7%), Alkem Laboratories Limited (0.6%), Gujarat State Petronet Limited (0.6%); the ten largest together made up 5.9% of the portfolio, and Chemicals & Petrochemicals was the biggest sector at 29.0% of its equity. Cash and debt stood at 92.1%.
Top-10 weight is higher than 0% of peers
Holds more stocks than 0% of peers
Holds more cash than 100% of peers
What these mean: concentration · cash
Every line the fund disclosed, with the change against the previous month. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Cash, TREPS & receivables | 92.13% | — | ₹1,214 Cr | — | |
| Atul Limited | 0.72% | — | ₹9.5 Cr | — | |
| Alkem Laboratories Limited | 0.60% | — | ₹8 Cr | — | |
| Gujarat State Petronet Limited | 0.60% | — | ₹7.9 Cr | — | |
| Coforge Limited | 0.60% | — | ₹7.9 Cr | — | |
| MphasiS Limited | 0.59% | — | ₹7.8 Cr | — | |
| Balkrishna Industries Limited | 0.58% | — | ₹7.6 Cr | — | |
| Aditya Birla Fashion and Retail Limited | 0.56% | — | ₹7.4 Cr | — | |
| Navin Fluorine International Limited | 0.56% | — | ₹7.4 Cr | — | |
| Max Healthcare Institute Limited | 0.55% | — | ₹7.2 Cr | — | |
| Vinati Organics Limited | 0.51% | — | ₹6.8 Cr | — | |
| Metropolis Healthcare Limited | 0.51% | — | ₹6.8 Cr | — | |
| Max Financial Services Limited | 0.50% | — | ₹6.6 Cr | — | |
| APL Apollo Tubes Limited | 0.50% | — | ₹6.6 Cr | — | |
| Aarti Industries Limited | 0.49% | — | ₹6.5 Cr | — |
This is the earliest month on record for the fund.
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
No earlier month with a sector split to compare against.
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Not enough months to draw.
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.
| 1.1% |
| — |
| Feb 2026 | ₹12,448 Cr | 72 | 22 | 35 | 2.1% | 2.1% | — |
| Jun 2025 | ₹12,146 Cr | 85 | 7 | 0 | 2.4% | 2.4% | — |
| Apr 2025 | ₹10,724 Cr | 78 | 1 | 1 | 1.2% | 1.2% | — |
| Mar 2025 | ₹10,362 Cr | 78 | 3 | 0 | 1.4% | 1.3% | — |
| Feb 2025 | ₹9,541 Cr | 75 | 5 | 3 | 2.5% | 2.5% | — |
| Dec 2024 | ₹12,416 Cr | 73 | 14 | 27 | 1.7% | 1.7% | — |
| Jun 2024 | ₹11,418 Cr | 86 | 4 | 9 | 1.9% | 1.9% | — |
| May 2024 | ₹10,584 Cr | 91 | 4 | 3 | 1.2% | 1.2% | — |
| Apr 2024 | ₹10,342 Cr | 90 | 31 | 20 | 1.5% | 1.5% | — |
| Nov 2023 | ₹8,848 Cr | 79 | 0 | 0 | 0.8% | 0.8% | — |
| Oct 2023 | ₹8,008 Cr | 79 | 1 | 4 | 1.0% | 1.0% | — |
| Sep 2023 | ₹8,151 Cr | 82 | 0 | 1 | 0.7% | 0.7% | — |
| Aug 2023 | ₹7,957 Cr | 83 | 1 | 3 | 0.9% | 0.9% | — |
| Jun 2023 | ₹7,526 Cr | 85 | 1 | 0 | 1.4% | 1.4% | 20% |
| May 2023 | ₹7,272 Cr | 84 | 2 | 2 | 4.0% | 4.0% | 22% |
| Apr 2023 | ₹7,048 Cr | 84 | 1 | 5 | 6.1% | 6.1% | 22% |
| Mar 2023 | ₹6,899 Cr | 88 | 1 | 8 | 6.0% | 6.0% | 19% |
| Feb 2023 | ₹6,981 Cr | 95 | 1 | 5 | 6.7% | 6.7% | 18% |
| Jan 2023 | ₹7,089 Cr | 99 | 1 | 7 | 5.1% | 5.0% | 15% |
For any of the 16 earlier months, choose it in “Portfolio as of” at the top of the page.